NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients
Clinical trial NCT06131424 · COMPLETED
Trial details
- NCT number
- NCT06131424
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-23
- Primary completion
- 2025-05-19
- Enrollment
- 1151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.